Search Results - "Favalli, E. G." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

by Iannone, F., Ferraccioli, G., Sinigaglia, L., Favalli, E. G., Sarzi-Puttini, P., Atzeni, F., Gorla, R., Bazzani, C., Govoni, M., Farina, I., Gremese, E., Carletto, A., Giollo, A., Galeazzi, M., Foti, R., Bianchino, L., La Grasta, L., Lapadula, G.
Published in Clinical rheumatology (01.02.2018)

Get full text

Journal Article

Is there really room for anti-rheumatic drugs in the treatment of COVID-19?

Is there really room for anti-rheumatic drugs in the treatment of COVID-19?

by Favalli, EG, Ingegnoli, F, Biggioggero, M, Caporali, R
Published in Scandinavian journal of rheumatology (02.09.2020)

Get full text

Journal Article

Pattern of use, economic burden and vial optimization of infliximab for rheumatoid arthritis in Italy

Pattern of use, economic burden and vial optimization of infliximab for rheumatoid arthritis in Italy

by FAVALLI, E. G, MARCHESONI, A, COLOMBO, G. L, SINIGAGLIA, L
Published in Clinical and experimental rheumatology (2008)

Get full text

Journal Article

POS0048 SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN RHEUMATIC PATIENTS TREATED WITH BIOLOGICAL AND TARGETED THERAPY LIVING IN LOMBARDY, ITALY (MAINSTREAM PROJECT)

POS0048 SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN RHEUMATIC PATIENTS TREATED WITH BIOLOGICAL AND TARGETED THERAPY LIVING IN LOMBARDY, ITALY (MAINSTREAM PROJECT)

by Favalli, E. G., Maioli, G., Bombaci, M., Biggioggero, M., Favalli, A., Agape, E., Andrea, G., Pesce, E., Zagato, E., Fabbris, T., Martinovic, M., Marchisio, E., Abrignani, S., Grifantini, R., Caporali, R.
Published in Annals of the rheumatic diseases (01.06.2021)

Get full text

Journal Article

POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

by Favalli, E. G., Iannone, F., Gremese, E., Gorla, R., Foti, R., Conti, F., Rossini, M., Fusaro, E., Cantatore, F. P., Montecucco, C., Sebastiani, M., Cauli, A., Ferraccioli, G., Lapadula, G., Caporali, R.
Published in Annals of the rheumatic diseases (01.06.2021)

Get full text

Journal Article

SAT0132 Comorbidities affect the retention rate but not the clinical response in a cohort of rheumatoid arthritis patients treated with tumor necrosis factor inhibitors

SAT0132 Comorbidities affect the retention rate but not the clinical response in a cohort of rheumatoid arthritis patients treated with tumor necrosis factor inhibitors

by Favalli, E. G., Biggioggero, M., Becciolini, A., Crotti, C., Sinigaglia, L.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy

Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy

by FAVALLI, E. G, VARENNA, M, SINIGAGLIA, L
Published in Clinical and experimental rheumatology (01.03.2005)

Get full text

Journal Article

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

by Ferrito, M, Cincinelli, G, Manara, M, Di Taranto, R, Favalli, E G, Caporali, R
Published in Reumatismo (17.07.2023)

Get full text

Journal Article

SAT0223 Predictive factors of early failure to first line treatment with methotrexate in patients with rheumatoid arthritis. results from the gisea registry

SAT0223 Predictive factors of early failure to first line treatment with methotrexate in patients with rheumatoid arthritis. results from the gisea registry

by Manfredi, A., Sebastiani, M., Iannone, F., Gremese, E., Bortoluzzi, A., Favalli, E. G., Gorla, R., Salaffi, F., Fusaro, E., Foti, R., Cantarini, L., Caporali, R., Cauli, A., Alivernini, S., Cantatore, F. P., Carletto, A., Conti, F., D'Angelo, S., Epis, O., Ramonda, R., Marchesoni, A., Atzeni, F., Sarzi-Puttini, P., Ferraccioli, G., Lapadula, G.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry

SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry

by Sebastiani, M., Manfredi, A., Iannone, F., Gremese, E., Bortoluzzi, A., Favalli, E. G., Gorla, R., Salaffi, F., Fusaro, E., Foti, R., Cantarini, L., Caporali, R., Cauli, A., Alivernini, S., Cantatore, F. P., Carletto, A., Conti, F., D'Angelo, S., Epis, O., Cassone, G., Ramonda, R., Grosso, V., Sarzi-Puttini, P., Ferraccioli, G., Lapadula, G.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

THU0151 Disease Duration and Year of Publication Affect the Results of Studies on Rheumatoid Arthritis Damage Progression by Biologic Agents: A Systematic Review and Meta-Analysis

THU0151 Disease Duration and Year of Publication Affect the Results of Studies on Rheumatoid Arthritis Damage Progression by Biologic Agents: A Systematic Review and Meta-Analysis

by Favalli, E. G., Biggioggero, M., Pregnolato, F., Meroni, P. L.
Published in Annals of the rheumatic diseases (01.06.2013)

Get full text

Journal Article

FRI0229 Survival on treatment of the second line biologic therapy: switch or swap strategy?

FRI0229 Survival on treatment of the second line biologic therapy: switch or swap strategy?

by Favalli, E. G., Biggioggero, M., Penatti, A. E., Marchesoni, A., Meroni, P. L.
Published in Annals of the rheumatic diseases (01.06.2013)

Get full text

Journal Article

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis

by Favalli, E G, Sinigaglia, L, Varenna, M, Arnoldi, C
Published in Lupus (01.01.2002)

Get full text

Journal Article

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

by Sarzi-Puttini, P, Antivalle, M, Marchesoni, A, Favalli, E G, Gorla, R, Filippini, M, Caporali, R, Bobbio-Pallavicini, F, Montecucco, C, Atzeni, F
Published in Reumatismo (01.10.2008)

Get full text

Journal Article

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

by Degli Esposti, Luca, Favalli, Ennio Giulio, Sangiorgi, Diego, Di Turi, Roberta, Farina, Giuseppina, Gambera, Marco, Ravasio, Roberto
Published in ClinicoEconomics and outcomes research (01.01.2017)

Get full text

Journal Article

POS0024 RETENTION RATE OF TNF INHIBITORS (TNFI), ANTI-IL17, AND ANTI-IL12/23 DRUGS IN A SINGLE-CENTER COHORT OF PSORIATIC ARTHRITIS PATIENTS

POS0024 RETENTION RATE OF TNF INHIBITORS (TNFI), ANTI-IL17, AND ANTI-IL12/23 DRUGS IN A SINGLE-CENTER COHORT OF PSORIATIC ARTHRITIS PATIENTS

by Ferrito, M, Cincinelli, G, Manara, M, Favalli, E G, Caporali, R
Published in Annals of the rheumatic diseases (01.06.2023)

Get full text

Journal Article

AB0671 PREVALENCE OF EXTRA-ARTICULAR MANIFESTATIONS AND IMPACT ON TARGETED DRUG PRESCRIPTION IN PATIENTS WITH SPONDYLOARTHRITIS: A RETROSPECTIVE ANALYSIS OF A REAL-LIFE COHORT

AB0671 PREVALENCE OF EXTRA-ARTICULAR MANIFESTATIONS AND IMPACT ON TARGETED DRUG PRESCRIPTION IN PATIENTS WITH SPONDYLOARTHRITIS: A RETROSPECTIVE ANALYSIS OF A REAL-LIFE COHORT

by Biggioggero, M., Favalli, E. G., Marchesoni, A., Caporali, R.
Published in Annals of the rheumatic diseases (01.06.2020)

Get full text

Journal Article

OP0061 TIGHT CONTROL IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TARGETED THERAPIES ACROSS THE COVID-19 PANDEMIC ERA

OP0061 TIGHT CONTROL IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TARGETED THERAPIES ACROSS THE COVID-19 PANDEMIC ERA

by Luppino, A. F., Cincinelli, G., Ingegnoli, F., Orenti, A., Favalli, E. G., Boracchi, P., Caporali, R.
Published in Annals of the rheumatic diseases (01.06.2022)

Get full text

Journal Article

POS0943 EFFECT OF NERIDRONATE ON AXIAL SPONDYLOARTHRITIS WHEN bDMARDs ARE NOT AN OPTION: RESULTS FROM A RESTROSPECTIVE STUDY

POS0943 EFFECT OF NERIDRONATE ON AXIAL SPONDYLOARTHRITIS WHEN bDMARDs ARE NOT AN OPTION: RESULTS FROM A RESTROSPECTIVE STUDY

by Crotti, C., DI Taranto, R., Favalli, E. G., Caporali, R.
Published in Annals of the rheumatic diseases (01.06.2022)

Get full text

Journal Article

POS0607 IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS

POS0607 IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS

by Gossec, L., Bessette, L., Xavier, R., Favalli, E. G., Ostor, A., Buch, M. H.
Published in Annals of the rheumatic diseases (01.06.2022)

Get full text

Journal Article